How does the CXCL16/CXCR6 axis affect the growth of neoplasms?
The CXCL16/CXCR6 axis is a signaling pathway involving a chemokine (CXCL16) and its corresponding receptor (CXCR6). In the context of neoplasms (tumors), this axis plays a complex and multifaceted role. Depending on the specific biological context and the types of cells involved, it can either help a tumor grow or be targeted to stop it.
What the research says
Research describes the CXCL16/CXCR6 axis as a "double-edged sword" because its effects on tumors are context-dependent. It can both inhibit and facilitate the progression of diseases like cancer 5. This complexity is partly due to the different roles of CXCL16 forms, such as membrane-bound and soluble versions, and the diversity found within the tumor microenvironment 5.
In specific cases, the axis promotes tumor growth and makes treatment harder. For example, in ovarian cancer, tumor-associated macrophages (TAMs) release CXCL16. This activates the CXCR6 receptor in cancer cells, which has been linked to increased resistance against chemotherapy drugs like cisplatin 7. In other cancers, such as hepatocellular carcinoma (HCC), high levels of both CXCL16 and CXCR6 are found in tumor tissues and are linked to a poorer prognosis for patients 8. In these cases, the axis is associated with an increase in neutrophils, which contribute to a pro-inflammatory environment that supports tumor growth 8.
Because of its role in promoting tumor growth and drug resistance, the CXCL16/CXCR6 axis is a target for new treatments. Studies have identified small molecule antagonists that block the CXCR6 receptor. In mouse models of hepatocellular carcinoma, these antagonists successfully slowed tumor growth 8.
What to ask your doctor
- How does the CXCL16/CXCR6 axis specifically affect the type of tumor I have?
- Can the CXCL16/CXCR6 axis contribute to resistance against my current chemotherapy?
- Are there any emerging targeted therapies or small molecule inhibitors that target the CXCR6 receptor?
- How does the tumor microenvironment, including immune cells like macrophages, influence my treatment options?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.